Understanding how to improve opioid treatment in primary care
Opioid Treatment Adoption in Primary Care Settings: Barriers and Facilitators to Implementation
['FUNDING_CAREER'] · EMORY UNIVERSITY · NIH-10883583
This study is looking at what makes it hard for doctors to offer effective treatments for opioid use disorder, like buprenorphine, and aims to find ways to make it easier for both doctors and patients to access these helpful medications.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10883583 on ClinicalTrials.gov |
What this research studies
This research investigates the barriers and facilitators to implementing effective opioid use disorder treatments in primary care settings. It focuses on improving access to medications that help individuals manage their condition, particularly buprenorphine maintenance therapy, which is underutilized despite its effectiveness. The study aims to identify the reasons why many healthcare providers do not prescribe these treatments and to develop strategies to overcome these challenges. By addressing both provider and patient-level obstacles, the research seeks to enhance the delivery of care for those struggling with opioid use disorder.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking treatment options.
Not a fit: Patients who are not diagnosed with opioid use disorder or those who are already receiving effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of patients receiving effective treatment for opioid use disorder, leading to better health outcomes and reduced overdose rates.
How similar studies have performed: Previous research has shown that addressing implementation barriers can improve treatment access and outcomes for opioid use disorder, indicating that this approach has potential for success.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YARBROUGH, COURTNEY R. — EMORY UNIVERSITY
- Study coordinator: YARBROUGH, COURTNEY R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.